These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 309196)

  • 1. Effect of cyclophosphamide and methylprednisolone on in vitro cellular immune response to allogeneic tumor cells. Correlation with in vivo rejection.
    Gerber M; Andress D; Pioch Y; Radal M; Serrou B
    Transplantation; 1978 Sep; 26(3):142-9. PubMed ID: 309196
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen.
    Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K
    J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
    Glaser M
    J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic differences in the cyclophosphamide-induced immune suppression: weaker suppression of T-cell cytotoxicity by cyclophosphamide activated by CBA mice.
    Hurme M; Bång BE; Sihvola M
    Clin Immunol Immunopathol; 1980 Sep; 17(1):38-42. PubMed ID: 6967785
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic comparisons of isolated pancreatic islet and whole-organ allografts.
    Reckard CR; Stuart FP; Schulak JA
    Transplant Proc; 1979 Mar; 11(1):563-6. PubMed ID: 109968
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of in vivo generation of cytotoxic activity against allograft. I. Local differentiation of mature cytotoxic T lymphocytes in rejection of allogeneic lymphocytes.
    Sakemi T; Kuroiwa A; Taniguchi K; Nomoto K
    Cell Immunol; 1980 Sep; 54(2):321-9. PubMed ID: 6968246
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cyclophosphamide on in vitro correlates of tumor immunity.
    Steele G; Sjögren HO; Ankerst J
    Int J Cancer; 1974 Dec; 14(6):743-52. PubMed ID: 4377004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.
    Röllinghoff M; Starzinski-Powitz A; Pfizenmaier K; Wagner H
    J Exp Med; 1977 Feb; 145(2):455-9. PubMed ID: 299883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon and the immunological system: cellular aspects].
    Jemma C
    Recenti Prog Med; 1981 Jan; 70(1):25-45. PubMed ID: 6170098
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.
    Hurme M
    J Exp Med; 1979 Jan; 149(1):290-4. PubMed ID: 153933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of immunological response induced in CD2F1 mice by administration of semisyngeneic L 1210 leukemia cells treated with cyclophosphamide.
    Skórski T; Kawalec M; Kawiak J
    Immunol Invest; 1987 Mar; 16(1):33-43. PubMed ID: 2956188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodiagnostic test for transplant rejection.
    Kahan BD; Tom BH; Mittal KK; Bergan JJ
    Lancet; 1974 Jan; 1(7846):37-42. PubMed ID: 4128833
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of the immune response by steroids. Comparative potency of hydrocortisone, methylprednisolone, and dexamethasone.
    Rosenberg JC; Lysz K
    Transplantation; 1980 May; 29(5):425-8. PubMed ID: 7376243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.